- Home
- LGCY
LGCY
LEGACY EDUCATION INC
as 01-17-2025 4:00pm EST
Stocks
Legacy Education Inc is engaged in career-focused, post-secondary education services to students at all stages of adult life, from recent high school graduates to working parents.
| Founded: | 2009 | Country: | United States |
| Employees: | N/A | City: | TEMECULA |
| Market Cap: | 101.9M | IPO Year: | 2024 |
| Target Price: | $9.35 | AVG Volume (30 days): | 100.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.63 | EPS Growth: | 90.87 |
| 52 Week Low/High: | $3.60 - $10.37 | Next Earning Date: | 11-14-2024 |
| Revenue: | $49,638,473 | Revenue Growth: | 32.36% |
| Revenue Growth (this year): | 32.23% | Revenue Growth (next year): | 20.60% |
Latest LEGACY EDUCATION INC News
LGCY Breaking Stock News: Dive into LGCY Ticker-Specific Updates for Smart Investing
Insider Monkey
2 days ago
Legacy Education Inc. (LGCY): A Bull Case Theory
PR Newswire
a month ago
Legacy Education Inc. Completes Acquisition of Contra Costa Medical Career College
PR Newswire
2 months ago
Legacy Education Reports First Quarter Fiscal 2025 Results; Continuing High Demand Drives Positive Growth Outlook
PR Newswire
2 months ago
LEGACY EDUCATION INC. SCHEDULES FIRST QUARTER FISCAL 2025 EARNINGS RELEASE AND CONFERENCE CALL
PR Newswire
3 months ago
Legacy Education Inc. Announces Agreement to Acquire Contra Costa Medical Career College, Expanding Access to Allied Health Education in Northern California
PR Newswire
3 months ago
Legacy Education Reports Results for Fourth Quarter and Full Year 2024
MT Newswires
3 months ago
Legacy Education Closes $11.5 Million IPO
PR Newswire
3 months ago
Legacy Education Inc. Announces Closing of $11.5 Million Initial Public Offering, Including Full Exercise of Underwriters' Over-Allotment Option
Compare LGCY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LGCY LEGACY EDUCATION INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.